
Rx Rundown: Eli Lilly, Teva, Vivo Capital and more
Deals: Merck Animal Health and Kansas announced a $895 million investment in manufacturing as well as research and development facilities in De Soto. Eli Lilly is set to pay up to $415 million in an ALS deal with Alchemab Therapeutics. Independent proxy …